National Guideline Clearinghouse | Home Updated Guideline Synthesis Screening and Diagnosis of Gestational Diabetes Mellitus New Guideline Summaries CancerControl Alberta View All Announcements Conference News The Guidelines International Network North America (G-I-N/NA) and the Section ...
NCCN Clinical Practice Guidelines in Oncology - National ... NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) are posted with the latest update date and version number. The NCCN Guidelines are ...
NCCN Clinical Practice Guidelines in Oncology - National ... NCCN Guidelines are widely recognized and used as the standard for ... tests and cancer precursors: 2012 updated consensus guidelines for the management ...
Tumor Markers - ARUP Consult, Your Online Lab Test Resource Tumor Type Marker Recommended Use Recommending Organizations* Colorectal BRAF V600E Lynch syndrome risk assessment NACB, NCCN CEA Monitoring ASCO, NACB, ESMO, NCCN Prognosis ASCO, ACS, NCCN, NACB (if used with other prognostic ...
Ramucirumab Misses Primary Endpoint in Phase III HCC Trial The phase III REACH trial, which examined ramucirumab (Cyramza) for the second-line treatment of patients with hepatocellular carcinoma (HCC), failed to meet its primary endpoint of overall survival (OS), as announced by Eli Lilly and Company, the sponsor
Brachytherapy - Noncoronary - 09/11 - Hawaii Medical Service Association Brachytherapy, Noncoronary 4 77326 Brachytherapy isodose plan, simple( calculation made from simple plan, 1 to 4 sources/ribbon application, remote afterloading brachytherapy ...
Molecular Markers in Solid Tumors: What Clinicians Need to Know: Introduction Introduction: Dr. Kelley reviews prognostic and predictive molecular tests that are included in NCCN Guidelines and are considered "ready for prime time." ... The NCCN staff listed below were involved in the planning and review of this activity and have n
SURG.00065 Locally Ablative Techniques for Treating Primary and Metastatic Liver Malignancies This document focuses on surgical excision, cryosurgical ablation, microwave ablation, radiofrequency ablation and percutaneous ethanol injection as ablative techniques to treat primary or metastatic cancer of the liver. Note: For related topics please se
RAD.00011 Transcatheter Arterial Chemoembolization (TACE) and Transcatheter Arterial Embolization (T Indications for the Use of TACE and TAE Catheter-based hepatic artery embolization procedures, with or without chemotherapeutic agents, are utilized for the palliative treatment of primary hepatic or metastatic tumors, as a primary treatment for surgicall
Liver and Other Neoplasms - Treatment Approaches Policy Percutaneous Ethanol Injection Aetna considers percutaneous ethanol injection (PEI) medically necessary for the treatment of hepatocellular cancers (HCC) without extra-hepatic spread. Aetna considers PEI for liver neoplasms experimental and ...
